We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
The Neuradiant 1070 is a transcranial photobiomodulation (tPBM) helmet that delivers near-infrared light to the scalp. It offers adjustable parameters for session time, intensity, and pulse rate, along with region-specific control across four areas of the head.
Full-Scalp LED Array uses 256 integrated LEDs distributed across the interior of the helmet to provide coverage across frontal, parietal, temporal, and occipital regions
4-Quadrant Output Control provides independent control of front, back, left, and right regions for region-specific activation during a session
Adjustable Fit System accommodates a range of head sizes with internal padding and hook-and-loop (Velcro) attachments for consistent positioning
Lightweight Construction keeps helmet weight at 560 g with balanced distribution for short-duration sessions without excessive bulk
Fixed LED Geometry maintains a consistent internal LED layout for repeatable positioning relative to scalp regions between sessions
Integrated Cable Connection uses a wired connection to an external controller with no onboard battery inside the helmet
Passive Thermal Design uses no active cooling components, with heat managed through operating parameters and session limits
Low-Profile Form Factor measures approximately 290 x 220 x 150 mm and is designed for seated, stationary use
Customizable Session Parameters allows users to adjust time, intensity, and pulse rate (up to 0-9999 Hz) for personalized session configurations
Transcranial Photobiomodulation (tPBM) uses near-infrared light to interact with brain tissue. Research shows that this light can penetrate the scalp and skull and influence cellular activity in cortical regions.
Proposed mechanisms include:
These mechanisms are still being studied and depend on wavelength, dose, and treatment parameters.
tPBM is an active area of research. Studies have explored its potential role in:
Outcomes vary significantly across studies, and findings should not be generalized to specific devices or users.
The 1064-1070 nm wavelength range is commonly used in transcranial photobiomodulation research. The choice of wavelength is one factor among many that influence outcomes.
Key considerations from published studies:
The Neuradiant 1070 is used in clinical and professional environments as a non-invasive, brain-focused modality that can be incorporated into structured protocols or offered as a standalone session.
Use is typically guided by practitioner experience, protocol design, and individual client needs.
It is typically positioned as a non-invasive adjunct modality, not a standalone intervention.